China Uranium Corporation's IPO on the Shenzhen Stock Exchange main board has been approved, focusing on the integrated utilization business of natural uranium and radioactive coexisting mineral resources.

On September 5th, China Uranium Corporation (referred to as China Uranium) passed the Shenzhen Stock Exchange Main Board IPO listing committee meeting. The sponsoring institution is China Securities Co., Ltd., with plans to raise 4.1 billion yuan. According to the prospectus, China Uranium is a mining company focusing on the comprehensive utilization of natural uranium and radioactive associated mineral resources. During the reporting period, China Uranium mainly engaged in the mining, smelting, sale, and trade of natural uranium resources, as well as the comprehensive utilization and product sales of radioactive associated mineral resources such as monazite and uranomolybdenum. China Uranium has successfully overcome challenges in multi-layered mining, "triple highs" (high calcium, high iron and aluminum, high mineralization) uranium leaching, and scattered ore body recovery, forming a complex sandstone uranium mine leaching technology system marked by the third generation in-situ leaching technology of CO2+O2. The company actively implements the national "Belt and Road" initiative, engaging in overseas uranium resource development business, focusing on Africa, Asia, and other major uranium-producing areas, with the Rossing Uranium Mine in Namibia ranking sixth globally in uranium mine production for 2022. China Uranium has abundant domestic and foreign natural uranium resources, with a total of 6 exploration rights and 19 mining rights domestically and abroad. It is a leading player in the industry in terms of production scale, being one of the major global natural uranium suppliers. According to WNA statistics, the top ten global natural uranium producers in 2022 accounted for over 90% of global natural uranium production, with the company consistently ranking among the top ten natural uranium producers globally in recent years, with a strong industry ranking. The company actively participates in global natural uranium market transactions, establishing a high market visibility and industry position. In terms of finances, China Uranium achieved operating revenues of approximately 10.535 billion yuan, 14.801 billion yuan, and 17.279 billion yuan in the years 2022, 2023, and 2024 respectively. During the same period, the company's net profits were approximately 1.52 billion yuan, 1.511 billion yuan, and 1.712 billion yuan respectively.